184 related articles for article (PubMed ID: 34263930)
21. The frequency of bleeding complications in patients with haematological malignancy following the introduction of a stringent prophylactic platelet transfusion policy.
Callow CR; Swindell R; Randall W; Chopra R
Br J Haematol; 2002 Aug; 118(2):677-82. PubMed ID: 12139764
[TBL] [Abstract][Full Text] [Related]
22. How low can you go: What is the safe threshold for platelet transfusions in patients with hematologic malignancy in sub-Saharan Africa.
Ddungu H; Krantz EM; Kajja I; Naluzze S; Nabbanja H; Nalubwama F; Phipps W; Orem J; Kiwanuka N; Wald A
PLoS One; 2019; 14(2):e0211648. PubMed ID: 30726290
[TBL] [Abstract][Full Text] [Related]
23. Preterm neonates benefit from low prophylactic platelet transfusion threshold despite varying risk of bleeding or death.
Fustolo-Gunnink SF; Fijnvandraat K; van Klaveren D; Stanworth SJ; Curley A; Onland W; Steyerberg EW; de Kort E; d'Haens EJ; Hulzebos CV; Huisman EJ; de Boode WP; Lopriore E; van der Bom JG;
Blood; 2019 Dec; 134(26):2354-2360. PubMed ID: 31697817
[TBL] [Abstract][Full Text] [Related]
24. A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10,000/L versus 20,000/microL trigger.
Zumberg MS; del Rosario ML; Nejame CF; Pollock BH; Garzarella L; Kao KJ; Lottenberg R; Wingard JR
Biol Blood Marrow Transplant; 2002; 8(10):569-76. PubMed ID: 12434952
[TBL] [Abstract][Full Text] [Related]
25. Compliance with prophylactic platelet transfusion trigger in haematological patients.
Eikenboom JC; van Wordragen R; Brand A
Transfus Med; 2005 Feb; 15(1):45-8. PubMed ID: 15713128
[TBL] [Abstract][Full Text] [Related]
26. Platelet Transfusion Practices in Critically Ill Children.
Nellis ME; Karam O; Mauer E; Cushing MM; Davis PJ; Steiner ME; Tucci M; Stanworth SJ; Spinella PC;
Crit Care Med; 2018 Aug; 46(8):1309-1317. PubMed ID: 29727368
[TBL] [Abstract][Full Text] [Related]
27. Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation.
Stanworth SJ; Hyde C; Heddle N; Rebulla P; Brunskill S; Murphy MF
Cochrane Database Syst Rev; 2004 Oct; (4):CD004269. PubMed ID: 15495093
[TBL] [Abstract][Full Text] [Related]
28. The Bleeding Risk Index: a clinical prediction rule to guide the prophylactic use of platelet transfusions in patients with lymphoma or solid tumors.
Elting LS; Martin CG; Kurtin DJ; Cantor SB; Rubenstein EB; Rodriguez S; Kanesan K; Vadhan-Raj S; Benjamin RS
Cancer; 2002 Jun; 94(12):3252-62. PubMed ID: 12115358
[TBL] [Abstract][Full Text] [Related]
29. Prophylactic platelet transfusions in patients with blood malignancies: cost analysis of a randomized trial.
Campbell HE; Estcourt LJ; Stokes EA; Llewelyn CA; Murphy MF; Wood EM; Stanworth SJ;
Transfusion; 2014 Oct; 54(10):2394-403. PubMed ID: 24826894
[TBL] [Abstract][Full Text] [Related]
30. Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 x 10(9) and 20 x 10(9) per L.
Nevo S; Fuller AK; Hartley E; Borinsky ME; Vogelsang GB
Transfusion; 2007 May; 47(5):801-12. PubMed ID: 17465944
[TBL] [Abstract][Full Text] [Related]
31. The TREATT Trial (TRial to EvaluAte Tranexamic acid therapy in Thrombocytopenia): safety and efficacy of tranexamic acid in patients with haematological malignancies with severe thrombocytopenia: study protocol for a double-blind randomised controlled trial.
Estcourt LJ; McQuilten Z; Powter G; Dyer C; Curnow E; Wood EM; Stanworth SJ;
Trials; 2019 Oct; 20(1):592. PubMed ID: 31615553
[TBL] [Abstract][Full Text] [Related]
32. Lowering the prophylactic platelet transfusion threshold: a prospective analysis.
Lawrence JB; Yomtovian RA; Hammons T; Masarik SR; Chongkolwatana V; Creger RJ; Manka A; Lazarus HM
Leuk Lymphoma; 2001 Mar; 41(1-2):67-76. PubMed ID: 11342358
[TBL] [Abstract][Full Text] [Related]
33. Randomized Trial of Platelet-Transfusion Thresholds in Neonates.
Curley A; Stanworth SJ; Willoughby K; Fustolo-Gunnink SF; Venkatesh V; Hudson C; Deary A; Hodge R; Hopkins V; Lopez Santamaria B; Mora A; Llewelyn C; D'Amore A; Khan R; Onland W; Lopriore E; Fijnvandraat K; New H; Clarke P; Watts T;
N Engl J Med; 2019 Jan; 380(3):242-251. PubMed ID: 30387697
[TBL] [Abstract][Full Text] [Related]
34. New thoughts on the correct dosing of prophylactic platelet transfusions to prevent bleeding.
Slichter SJ
Curr Opin Hematol; 2011 Nov; 18(6):427-35. PubMed ID: 21946073
[TBL] [Abstract][Full Text] [Related]
35. Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders.
Wardrop D; Estcourt LJ; Brunskill SJ; Doree C; Trivella M; Stanworth S; Murphy MF
Cochrane Database Syst Rev; 2013 Jul; (7):CD009733. PubMed ID: 23897323
[TBL] [Abstract][Full Text] [Related]
36. Measuring bleeding as an outcome in clinical trials of prophylactic platelet transfusions.
Bercovitz RS; O'Brien SH
Hematology Am Soc Hematol Educ Program; 2012; 2012():157-60. PubMed ID: 23233575
[TBL] [Abstract][Full Text] [Related]
37. Rationale and design of platelet transfusions in haematopoietic stem cell transplantation: the PATH pilot study.
Tay J; Allan D; Beattie S; Bredeson C; Fergusson D; Maze D; Sabloff M; Thavorn K; Tinmouth A
BMJ Open; 2016 Oct; 6(10):e013483. PubMed ID: 27798034
[TBL] [Abstract][Full Text] [Related]
38. Platelet transfusion prophylaxis for patients with haematological malignancies: where to now?
Stanworth SJ; Hyde C; Brunskill S; Murphy MF
Br J Haematol; 2005 Dec; 131(5):588-95. PubMed ID: 16351634
[TBL] [Abstract][Full Text] [Related]
39. Agonist-induced platelet reactivity correlates with bleeding in haemato-oncological patients.
Batman B; van Bladel ER; van Hamersveld M; Pasker-de Jong PCM; Korporaal SJA; Urbanus RT; Roest M; Boven LA; Fijnheer R
Vox Sang; 2017 Nov; 112(8):773-779. PubMed ID: 28960383
[TBL] [Abstract][Full Text] [Related]
40. Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia.
Wandt H; Frank M; Ehninger G; Schneider C; Brack N; Daoud A; Fackler-Schwalbe I; Fischer J; Gäckle R; Geer T; Harms P; Löffler B; Ohl S; Otremba B; Raab M; Schönrock-Nabulsi P; Strobel G; Winter R; Link H
Blood; 1998 May; 91(10):3601-6. PubMed ID: 9572994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
